Abstract
To identify incidence of antibody to hepatitis C virus among 265 male prison inmates, we assayed paired serum specimens obtained at intake in 1985–1986 with follow-up specimens in 1987. Intake prevalence was 38 percent. Seroincidence was 1.1/100 person years in prison. This finding might reflect saturation of high-risk subgroups or possibly reduced frequency of exposures following incarceration.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alter M.J., Coleman T.J., Alexander J., et al. (1989): Importance of heterosexual activity in transmission of hepatitis B and non-A non-B hepatitis - JAMA 262: 1201–1205.
Alter M.J., Purcell R.H., Shih J.W., et al. (1989): Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis - New Engl. J. Med. 321: 1494–1500.
Alter M.J., Margolis H.S., Krawozynski K., et al. (1992): The natural history of community acquired hepatitis C in the United States - N. Engl. J. Med. 327: 1899–1905.
Brewer T.F., Vlahov D., Taylor E., Hall D., Munoz A. and Polk B.F. (1988): Transmission of HIV-1 within a statewide prison system - AIDS 2: 363–367.
Decker M.D., Vaugh W.K., Brodie J.S., et al. (1984): Seroepidemiology of hepatitis B in Tennessee prisoners - J. Infect. Dis. 150: 450–459.
Decker M.D., Vaugh W.K., Brodie J.S., et al. (1985): The incidence of hepatitis B in Tennessee prisoners -J. Infect. Dis. 152: 214–217.
Donahue J.G., Nelson K.E., Munoz A., et al. (1991): Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland - Am. J. Epidemiol. 134: 1206–1211.
Esteban J.I., Esteban R., Viladomiu L., et al. (1989): Hepatitis C virus antibodies among risk groups in Spain - Lancet 2: 294–297.
Mortimer P.P., Cohen B.J., Litton P.A., et al. (1989): Hepatitis C virus antibody (letter) - Lancet 2: 798.
Nacci P.L. and Kane T.R. (1982): Sex and sexual aggression in federal prisons, Washington D. C., Department of Justice: Progress Reports.
Prefontaine R.G. and Chaudhary R.K. (1990): Seroepidemiologic study of hepatitis B and C viruses in federal correctional institutions in British Columbia - Canadian Disease Weekly Report 16: 265–266.
Stevens C.E., Taylor P.E., Pindyck J., et al. (1990): Epidemiology of hepatitis C virus. A preliminary study in volunteer blood donors - JAMA 263: 49–53.
Tremolada F., Casarin C., Tagger A., et al. (1991): Antibody to hepatitis C virus in post-transfusion hepatitis - Ann. Intern. Med. 114: 277–281.
Vlahov D. and Polk B.F. (1988): Intravenous drug use and human immunodeficiency virus (HIV) infection in prison - AIDS Public Pol. J. 3: 42–46.
Vlahov D., Brewer F., Munoz A., et al. (1989): Temporal trends of human immunodeficiency virus type 1 (HIV-1) infection among inmates entering a statewide prison system 1985–1987 - J. Acquir. Immune Defic. Syndr. 2: 283–290.
Vlahov D., Brewer T.F., Castro K.G., et al. (1991): Prevalence of antibody to HIV-1 among entrants to US correctional facilities - JAMA 265: 1129–1132.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vlahov, D., Nelson, K.E., Quinn, T.C. et al. Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland. Eur J Epidemiol 9, 566–569 (1993). https://doi.org/10.1007/BF00209538
Issue Date:
DOI: https://doi.org/10.1007/BF00209538